CID 16396350

Details

Top
Internal ID 609e15d8-eb0c-4e34-8678-a7d86b88b819
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (2S,7S)-3,3,7-trimethyl-8-methylidenetricyclo[5.4.0.02,9]undecane
SMILES (Canonical) CC1(CCCC2(C3C1C(C2=C)CC3)C)C
SMILES (Isomeric) C[C@]12CCCC([C@@H]3C1CCC3C2=C)(C)C
InChI InChI=1S/C15H24/c1-10-11-6-7-12-13(11)14(2,3)8-5-9-15(10,12)4/h11-13H,1,5-9H2,2-4H3/t11?,12?,13-,15+/m0/s1
InChI Key PDSNLYSELAIEBU-NSOJWWLLSA-N
Popularity 53 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 5.10
Atomic LogP (AlogP) 4.42
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 0

Synonyms

Top
475-20-7
AKOS030490876

2D Structure

Top
2D Structure of CID 16396350

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9917 99.17%
Caco-2 + 0.7297 72.97%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Lysosomes 0.7752 77.52%
OATP2B1 inhibitior - 0.8448 84.48%
OATP1B1 inhibitior + 0.8707 87.07%
OATP1B3 inhibitior + 0.8296 82.96%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.6500 65.00%
BSEP inhibitior - 0.8896 88.96%
P-glycoprotein inhibitior - 0.9267 92.67%
P-glycoprotein substrate - 0.9392 93.92%
CYP3A4 substrate + 0.5362 53.62%
CYP2C9 substrate - 0.7890 78.90%
CYP2D6 substrate - 0.7441 74.41%
CYP3A4 inhibition - 0.8639 86.39%
CYP2C9 inhibition - 0.7857 78.57%
CYP2C19 inhibition - 0.7457 74.57%
CYP2D6 inhibition - 0.9386 93.86%
CYP1A2 inhibition - 0.7484 74.84%
CYP2C8 inhibition - 0.6354 63.54%
CYP inhibitory promiscuity - 0.6722 67.22%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7500 75.00%
Carcinogenicity (trinary) Non-required 0.4950 49.50%
Eye corrosion - 0.9480 94.80%
Eye irritation + 0.9708 97.08%
Skin irritation + 0.5266 52.66%
Skin corrosion - 0.9769 97.69%
Ames mutagenesis - 0.9000 90.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5492 54.92%
Micronuclear - 1.0000 100.00%
Hepatotoxicity + 0.6517 65.17%
skin sensitisation + 0.8187 81.87%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity - 0.5889 58.89%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity + 0.4655 46.55%
Acute Oral Toxicity (c) III 0.7957 79.57%
Estrogen receptor binding - 0.8790 87.90%
Androgen receptor binding + 0.5904 59.04%
Thyroid receptor binding - 0.8098 80.98%
Glucocorticoid receptor binding - 0.6194 61.94%
Aromatase binding - 0.7369 73.69%
PPAR gamma - 0.8146 81.46%
Honey bee toxicity - 0.8612 86.12%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity + 0.9200 92.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.78% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.84% 91.11%
CHEMBL4370 P16662 UDP-glucuronosyltransferase 2B7 89.81% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.00% 97.09%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.57% 96.09%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.50% 95.89%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.10% 100.00%
CHEMBL5203 P33316 dUTP pyrophosphatase 84.15% 99.18%
CHEMBL241 Q14432 Phosphodiesterase 3A 84.06% 92.94%
CHEMBL238 Q01959 Dopamine transporter 83.97% 95.88%
CHEMBL233 P35372 Mu opioid receptor 83.63% 97.93%
CHEMBL237 P41145 Kappa opioid receptor 82.57% 98.10%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 82.53% 95.50%

Cross-Links

Top
PubChem 16396350
LOTUS LTS0085446
wikiData Q104249690